Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Sirtori

Showing results (1-10 of 273) with videos related to

Pageof 28
Sort By:
Drug Safety|August 28, 2001
Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosisC R Sirtori
Cardiologia (Rome, Italy)|December 25, 2002
[Pharmacologic treatment with statins]C R Sirtori
The American Journal of Cardiology|May 30, 1998
Early efficacy and safety studiesC R Sirtori
Lancet (London, England)|March 11, 2000
Dubious benefits and potential risk of soy phyto-oestrogensC R Sirtori
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1995
[The treatment of hypercholesterolemia in primary and secondary prevention]C R Sirtori
Lancet (London, England)|June 20, 1981
Mechanism of action of clofibrateC R Sirtori
Advances in Experimental Medicine and Biology|January 1, 1985
Mechanisms of action of absorbable hypolipidemic drugsC R Sirtori
Pharmacological Research|September 1, 1990
Pharmacology and mechanism of action of the new HMG-CoA reductase inhibitorsC R Sirtori
World Review of Nutrition and Dietetics|January 1, 1994
Effects of unsaturated fatty acids on high density lipoprotein metabolismC R Sirtori
Pharmacology & Therapeutics|December 1, 1993
Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitorsC R Sirtori
Pageof 28

Showing results (1-10 of 273) with videos related to

Sort By:
Pageof 28
Drug Safety|August 28, 2001
Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosisC R Sirtori
Cardiologia (Rome, Italy)|December 25, 2002
[Pharmacologic treatment with statins]C R Sirtori
The American Journal of Cardiology|May 30, 1998
Early efficacy and safety studiesC R Sirtori
Lancet (London, England)|March 11, 2000
Dubious benefits and potential risk of soy phyto-oestrogensC R Sirtori
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1995
[The treatment of hypercholesterolemia in primary and secondary prevention]C R Sirtori
Lancet (London, England)|June 20, 1981
Mechanism of action of clofibrateC R Sirtori
Advances in Experimental Medicine and Biology|January 1, 1985
Mechanisms of action of absorbable hypolipidemic drugsC R Sirtori
Pharmacological Research|September 1, 1990
Pharmacology and mechanism of action of the new HMG-CoA reductase inhibitorsC R Sirtori
World Review of Nutrition and Dietetics|January 1, 1994
Effects of unsaturated fatty acids on high density lipoprotein metabolismC R Sirtori
Pharmacology & Therapeutics|December 1, 1993
Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitorsC R Sirtori
Pageof 28